Associate Director, Global Health Economics and Outcomes Research (GHEOR) Neuroscience
Bristol Myers Squibb
Summary
Contributes to the development of GHEOR strategy and tactics for one or more indications within the neuroscience portfolio, with input from key stakeholders across Clinical, Medical, Marketing, Market Access, Biostatistics, and Regulatory.
Job description
Summary
Contributes to the development of GHEOR strategy and tactics for one or more indications within the neuroscience portfolio, with input from key stakeholders across Clinical, Medical, Marketing, Market Access, Biostatistics, and Regulatory.
Responsibilities
- Support the development of an aligned strategy for GHEOR to demonstrate the value of neuroscience assets with a focus on psychiatry indications (schizophrenia, bipolar, etc.).
- Develop and execute innovative GHEOR plans, including real-world evidence generation, economic modeling, and clinical outcome assessment (COA).
- Effectively lead scientifically rigorous HEOR studies and manage projects from concept through execution, including dissemination of evidence through scientific congress presentations, peer-reviewed publications, and field-related materials.
- Maintain cross-functional collaborative relationships with internal stakeholders including, but not limited to, Access Strategy, Clinical, Medical Affairs, and Commercial.
- Provide input into clinical trial design and endpoint selection aligned with the value demonstration strategy.
Qualifications
- A PhD in a related discipline such as Epidemiology, Health Economics, or Health Services Research is preferred.
- A minimum of a Master's degree in a related discipline is required.
- At least 3 years of experience conducting outcomes research, health economics research, health services research, health technology assessment or conducting epidemiologic studies.
- Experience executing research in a matrix organization, preferably within a pharmaceutical company setting.
- Very strong written and verbal communication skills, with the ability to distill complex issues into clear and actionable insights for stakeholders.
- Experience in neuroscience is preferred.
Requirements
- A minimum of a Master's degree in a related discipline is required.
- At least 3 years of experience conducting outcomes research, health economics research, health services research, health technology assessment or conducting epidemiologic studies.
- Experience executing research in a matrix organization, preferably within a pharmaceutical company setting.
- Very strong written and verbal communication skills, with the ability to distill complex issues into clear and actionable insights for stakeholders.
- A PhD in a related discipline such as Epidemiology, Health Economics, or Health Services Research is preferred.
- Experience in neuroscience is preferred.
Benefits
- Wellbeing support
- Retirement benefits
- Financial protection benefits
- Medical insurance
- Dental insurance
- Vision insurance
- Life insurance
- Disability insurance
- Flexible Time Off
- Paid company holidays
- Paid sick leave
- Volunteer days
- Summer hours flexibility
- Leaves of absence
- Global shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.